Laura L. Parks - 14 Jun 2021 Form 4 Insider Report for Recro Pharma, Inc.

Role
Director
Signature
/s/ Ryan D. Lake
Issuer symbol
N/A
Transactions as of
14 Jun 2021
Net transactions value
$0
Form type
4
Filing time
21 Jun 2021, 11:56:06 UTC
Next filing
20 May 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SCTL Stock Option (right to buy) Award $0 +20,000 $0.000000 20,000 14 Jun 2021 Common Stock 20,000 $2.23 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option will vest in three equal annual installments, beginning on June 14, 2022, subject to the Reporting Person's continuous service with the Company.